📣 VC round data is live. Check it out!

Lifeward Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lifeward and similar public comparables like Icecure Medical, Co-Diagnostics, Geratherm Medical, Iridex and more.

Lifeward Overview

About Lifeward

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.


Founded

2001

HQ

United States

Employees

80

Financials (LTM)

Revenue: $25M
Net Income: ($20M)

EV

$17M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lifeward Financials

Lifeward reported last 12-month revenue of $25M.

In the same LTM period, Lifeward generated $10M in gross profit and had net loss of ($20M).

Revenue (LTM)


Lifeward P&L

In the most recent fiscal year, Lifeward reported revenue of $22M and EBITDA of ($17M).

Lifeward is unprofitable as of last fiscal year, with gross margin of 38%, EBITDA margin of (75%), and net margin of (90%).

See analyst estimates for Lifeward
LTMLast FY202320242025202620272028
Revenue$25M$22M$14M$26M$22M
Gross Profit$10M$8M$4M$8M$8M
Gross Margin41%38%32%32%38%
EBITDA($17M)($22M)($16M)($17M)
EBITDA Margin(75%)(157%)(61%)(75%)
EBIT Margin(61%)(69%)(170%)(76%)(77%)
Net Profit($20M)($20M)($22M)($29M)($20M)
Net Margin(79%)(90%)(160%)(113%)(90%)
Net Debt$634K

Financial data powered by Morningstar, Inc.

Lifeward Stock Performance

Lifeward has current market cap of $19M, and enterprise value of $17M.

Market Cap Evolution


Lifeward's stock price is $6.97.

Lifeward share price decreased by 3.9% in the last 30 days, and by 52.8% in the last year.

Lifeward has an EPS (earnings per share) of $-7.17.

See more trading valuation data for Lifeward
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$17M$19M0.0%-3.9%-5.8%-52.8%$-7.17

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lifeward Valuation Multiples

Lifeward trades at 0.7x EV/Revenue multiple, and (1.0x) EV/EBITDA.

See NTM and 2027E valuation multiples for Lifeward

EV / Revenue (LTM)


Lifeward Financial Valuation Multiples

As of May 26, 2026, Lifeward has market cap of $19M and EV of $17M.

Lifeward has a P/E ratio of (1.0x).

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.8x1.2x0.7x0.8x
EV/EBITDA(1.0x)(0.8x)(1.1x)(1.0x)
EV/EBIT(1.1x)(1.1x)(0.7x)(0.9x)(1.0x)
EV/Gross Profit1.6x2.0x3.8x2.0x2.0x
P/E(1.0x)(1.0x)(0.9x)(0.7x)(1.0x)
EV/FCF(1.0x)(0.8x)(0.8x)(1.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lifeward Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lifeward Margins & Growth Rates

Lifeward grew revenue by 34% but net profit decreased by 2% in the last fiscal year.

In the most recent fiscal year, Lifeward reported gross margin of 38%, EBITDA margin of (75%), and net margin of (90%).

See estimated margins and future growth rates for Lifeward

Lifeward Margins

Last FY202420252026202720282029
Gross Margin38%32%38%44%
EBITDA Margin(75%)(61%)(75%)
EBIT Margin(69%)(76%)(77%)(52%)
Net Margin(90%)(113%)(90%)(66%)
FCF Margin(76%)(85%)(76%)

Lifeward Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth34%85%(14%)34%
Gross Profit Growth54%85%3%54%
EBITDA Growth(28%)5%
EBIT Growth2%(17%)(14%)(9%)
Net Profit Growth(2%)31%(31%)(2%)
FCF Growth5%(22%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Lifeward Operational KPIs

Lifeward's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.

Access forward-looking KPIs for Lifeward
LTMLast FY202320242025202620272028
Revenue per Employee$0.3M
Opex per Employee$0.3M
S&M Expenses to Revenue56%63%100%70%63%
G&A Expenses to Revenue36%37%72%20%37%
R&D Expenses to Revenue18%15%30%18%15%
Opex to Revenue115%203%108%115%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lifeward Competitors

Lifeward competitors include Icecure Medical, Co-Diagnostics, Geratherm Medical, Iridex, Elbit Imaging, Cambridge Cognition, Promimic, Scandinavian Real Heart, Inspira Technologies and Integrum.

Most Lifeward public comparables operate across Medical Devices, HealthTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Icecure Medical3.3x2.4x(0.8x)
Co-Diagnostics19.9x19.9x(0.4x)
Geratherm Medical0.4x2.7x
Iridex0.4x0.4x9.5x14.0x
Elbit Imaging
Cambridge Cognition1.7x1.5x(31.1x)(88.9x)
Promimic4.1x(92.3x)
Scandinavian Real Heart(4.1x)

This data is available for Pro users. Sign up to see all Lifeward competitors and their valuation data.

Start Free Trial

Lifeward Funding History

Before going public, Lifeward raised $18M in total equity funding, across 2 rounds.


Lifeward Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Sep-13Series EBearing Capital; Yaskawa$17M
Jun-13Series DIsrael Healthcare Ventures; OurCrowd; Pontifax; SCP Vitalife Partners$1M

Lifeward M&A Activity

Lifeward has acquired 2 companies to date.

Last acquisition by Lifeward was on March 25th 2026. Lifeward acquired OraTech Pharmaceuticals for $47M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Lifeward

OraTech Pharmaceuticals
AlterG
Description
OraTech Pharmaceuticals develops and commercializes Protein Oral Delivery (POD™) technology to convert injectable protein medications into oral capsules by protecting them from gastric acid and improving intestinal absorption.
AlterG is a Fremont-headquartered developer of differential air pressure technology featured in the Anti-Gravity Treadmill for physical therapy and athletic training. The system enables precise body weight reduction during gait and mobility exercises, supporting rehabilitation in clinics, sports facilities, and performance centers worldwide.
HQ CountryUnited States
HQ City
San Francisco, CA
Deal Date25 Mar 20268 Aug 2023
Valuation$47M$19M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Lifeward acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lifeward

When was Lifeward founded?Lifeward was founded in 2001.
Where is Lifeward headquartered?Lifeward is headquartered in United States.
How many employees does Lifeward have?As of today, Lifeward has over 80 employees.
Who is the CEO of Lifeward?Lifeward's CEO is William Mark Grant.
Is Lifeward publicly listed?Yes, Lifeward is a public company listed on Nasdaq.
What is the stock symbol of Lifeward?Lifeward trades under LFWD ticker.
When did Lifeward go public?Lifeward went public in 2014.
Who are competitors of Lifeward?Lifeward main competitors include Icecure Medical, Co-Diagnostics, Geratherm Medical, Iridex, Elbit Imaging, Cambridge Cognition, Promimic, Scandinavian Real Heart, Inspira Technologies, Integrum.
What is the current market cap of Lifeward?Lifeward's current market cap is $19M.
What is the current revenue of Lifeward?Lifeward's last 12 months revenue is $25M.
What is the current revenue growth of Lifeward?Lifeward revenue growth (NTM/LTM) is 54%.
What is the current EV/Revenue multiple of Lifeward?Current revenue multiple of Lifeward is 0.7x.
Is Lifeward profitable?No, Lifeward is not profitable.
What is the current net income of Lifeward?Lifeward's last 12 months net income is ($20M).
How many companies Lifeward has acquired to date?As of May 2026, Lifeward has acquired 2 companies.
What was the largest acquisition by Lifeward?$47M acquisition of OraTech Pharmaceuticals on 25th March 2026 was the largest M&A Lifeward has done to date.
What companies Lifeward acquired?Lifeward acquired OraTech Pharmaceuticals and AlterG.
In how many companies Lifeward has invested to date?Lifeward hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Lifeward

Lists including Lifeward

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial